News Quantified

RCEL – avita medical, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand [Yahoo! Finance]

AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand

AVITA Medical, Inc. (NASDAQ:RCEL) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year [Yahoo! Finance]

AVITA Medical, Inc. (NASDAQ: RCEL) had its "neutral" rating re-affirmed by analysts at Piper Sandler. They now have a $12.00 price target on the stock, up previously from $9.00.

AVITA Medical to Host Investor Webinar Briefing

-2.8%

MISS

20.7%

MISS

4.4%

MISS

0.5%

BEAT

Form 10-Q AVITA Medical, Inc. For: Sep 30

Form 8-K AVITA Medical, Inc. For: Nov 07

Top News Gainers

4/6 AVITA MED LTD/S ADR (NASDAQ: RCEL) had its "buy" rating re-affirmed by analysts at BTIG Research. They now have a $8.00 price target on the stock. 12.2%

2/9 Did The Underlying Business Drive Avita Medical's (ASX:AVH) Lovely 730% Share Price Gain? [Yahoo! Finance News] 7.4%

3/3 AVITA Medical to Attend the 2020 BTIG Healthcare Conference 4.3%

1/29 AVITA MED LTD/S ADR (NASDAQ: RCEL) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 4.3%

4/25 AVITA MED LTD/S ADR (NASDAQ: RCEL) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $6.25 price target on the stock. 3.1%

10/30 AVITA Medical Reports First Quarter Fiscal 2020 Financial Results and Company Update 2.7%

12/29 AVITA Medical Receives U.S. FDA Investigational Device Exemption Approval of Clinical Feasibility Study to Evaluate RECELL System for Vitiligo 2.1%

12/6 Australia shares advance despite trade talk angst; NZ inches higher [Reuters] 1.8%

4/1 RECELL® System Data Accepted to 52nd Annual American Burn Association Meeting Available Online 1.8%

2/3 Form 6-K Avita Medical, Ltd. For: Feb 03 1.2%

Top News Decliners

3/17 AVITA MED LTD/S ADR (NASDAQ: RCEL) was downgraded by analysts at ValuEngine from a "sell" rating to a "strong sell" rating. -19.2%

11/13 Form 6-K Avita Medical, Ltd. For: Nov 13 -10.1%

4/20 AVITA MED LTD/S ADR (NASDAQ: RCEL) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating on the stock. -10.0%

3/4 Avita Medical launches pivotal study of Recell in kids [Seeking Alpha] -7.6%

11/19 Form 20-F/A Avita Medical, Ltd. For: Jun 30 -7.6%

2/19 Form 6-K Avita Medical, Ltd. For: Feb 18 -7.2%

4/15 Form 6-K Avita Medical, Ltd. For: Apr 06 -5.6%

1/31 Australia, NZ shares helped by China PMI; virus anxiety caps gains [Reuters] -5.4%

3/6 AVITA MED LTD/S ADR (NASDAQ: RCEL) had its "buy" rating re-affirmed by analysts at Lake Street Capital. They now have a $12.00 price target on the stock. -5.1%

11/12 AVITA Medical Announces Institutional Placement of A$120.0 Million to Support Commercial Growth and Pipeline Development -4.2%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day